ATAI Life Sciences NV (FRA:9VC) ROE % Adjusted to Book Value : -67.48% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV ROE % Adjusted to Book Value?

ATAI Life Sciences NV's ROE % for the quarter that ended in Dec. 2024 was -122.81%. ATAI Life Sciences NV's PB Ratio for the quarter that ended in Dec. 2024 was 1.82. ATAI Life Sciences NV's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -67.48%.

ATAI Life Sciences NV ROE % Adjusted to Book Value Historical Data

The historical data trend for ATAI Life Sciences NV's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV ROE % Adjusted to Book Value Chart

ATAI Life Sciences NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-23.03

-31.02

-15.57

-46.92

ATAI Life Sciences NV Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-28.13	-34.58	-85.57	-49.59	-67.48

Competitive Comparison of ATAI Life Sciences NV's ROE % Adjusted to Book Value

For the Biotechnology subindustry, ATAI Life Sciences NV's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ATAI Life Sciences NV's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ATAI Life Sciences NV's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ATAI Life Sciences NV's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

ATAI Life Sciences NV ROE % Adjusted to Book Value Calculation

ATAI Life Sciences NV's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-85.40%	/	1.82
	=	-46.92%

ATAI Life Sciences NV's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-122.81%	/	1.82
	=	-67.48%

ATAI Life Sciences NV ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

ATAI Life Sciences NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ATAI:USA 9VC:Germany

Address

Wallstrasse 16, Berlin, BB, DEU, 10179

Website

https://www.atai.life

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

ATAI Life Sciences NV Headlines

No Headlines